| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Keratoconus | 15 | 2019 | 42 | 8.91 | Why? |
| Corneal Topography | 17 | 2019 | 45 | 5.53 | Why? |
| Myopia | 12 | 2020 | 189 | 4.45 | Why? |
| Cornea | 15 | 2019 | 410 | 4.34 | Why? |
| Keratomileusis, Laser In Situ | 10 | 2020 | 31 | 4.33 | Why? |
| Visual Acuity | 18 | 2019 | 790 | 3.37 | Why? |
| Lasers, Excimer | 8 | 2020 | 37 | 2.73 | Why? |
| Refraction, Ocular | 9 | 2019 | 108 | 2.64 | Why? |
| Corneal Stroma | 7 | 2020 | 26 | 2.50 | Why? |
| Corneal Wavefront Aberration | 4 | 2019 | 6 | 2.39 | Why? |
| Corneal Surgery, Laser | 4 | 2019 | 7 | 1.88 | Why? |
| Aberrometry | 4 | 2019 | 7 | 1.66 | Why? |
| Eye Proteins | 4 | 2019 | 42 | 1.65 | Why? |
| Fluorescein Angiography | 5 | 2021 | 426 | 1.61 | Why? |
| Epithelium, Corneal | 4 | 2018 | 69 | 1.58 | Why? |
| Uveitis, Anterior | 2 | 2021 | 71 | 1.53 | Why? |
| Tonometry, Ocular | 3 | 2020 | 108 | 1.46 | Why? |
| Intraocular Pressure | 4 | 2020 | 276 | 1.43 | Why? |
| Tears | 4 | 2020 | 400 | 1.43 | Why? |
| Conjunctivitis, Allergic | 2 | 2020 | 94 | 1.38 | Why? |
| Cross-Linking Reagents | 2 | 2018 | 91 | 1.38 | Why? |
| Ophthalmologists | 4 | 2021 | 401 | 1.24 | Why? |
| Tomography, Optical Coherence | 10 | 2021 | 1008 | 1.22 | Why? |
| Retinal Vessels | 2 | 2019 | 255 | 1.15 | Why? |
| Photochemotherapy | 2 | 2018 | 297 | 0.96 | Why? |
| Corneal Pachymetry | 3 | 2017 | 12 | 0.92 | Why? |
| Astigmatism | 2 | 2018 | 6 | 0.91 | Why? |
| Diagnostic Techniques, Ophthalmological | 3 | 2018 | 136 | 0.90 | Why? |
| Ophthalmologic Surgical Procedures | 2 | 2021 | 211 | 0.87 | Why? |
| Allergens | 2 | 2017 | 728 | 0.86 | Why? |
| Ophthalmology | 6 | 2021 | 1840 | 0.85 | Why? |
| Panuveitis | 1 | 2021 | 46 | 0.85 | Why? |
| Uveitis | 2 | 2021 | 233 | 0.85 | Why? |
| Refractive Surgical Procedures | 1 | 2020 | 26 | 0.85 | Why? |
| Optic Disk | 1 | 2021 | 66 | 0.84 | Why? |
| Retinal Artery Occlusion | 1 | 2021 | 57 | 0.81 | Why? |
| Choroiditis | 1 | 2019 | 18 | 0.80 | Why? |
| Surgical Flaps | 3 | 2020 | 188 | 0.80 | Why? |
| Iris Diseases | 1 | 2019 | 6 | 0.79 | Why? |
| Dental Bonding | 1 | 2019 | 10 | 0.79 | Why? |
| Eye Diseases | 5 | 2021 | 1150 | 0.77 | Why? |
| Dilatation, Pathologic | 5 | 2019 | 78 | 0.76 | Why? |
| Keratectomy | 1 | 2018 | 8 | 0.76 | Why? |
| Optic Neuritis | 1 | 2021 | 132 | 0.76 | Why? |
| Protein-Lysine 6-Oxidase | 1 | 2018 | 12 | 0.74 | Why? |
| Retinal Vein Occlusion | 1 | 2021 | 129 | 0.74 | Why? |
| Photophobia | 1 | 2018 | 14 | 0.73 | Why? |
| Aerosols | 5 | 2021 | 5393 | 0.73 | Why? |
| Anterior Chamber | 1 | 2018 | 26 | 0.72 | Why? |
| Trigeminal Nerve Diseases | 1 | 2018 | 21 | 0.72 | Why? |
| Surgery, Computer-Assisted | 2 | 2018 | 183 | 0.72 | Why? |
| Retinal Hemorrhage | 1 | 2019 | 50 | 0.72 | Why? |
| Choroid | 1 | 2019 | 112 | 0.72 | Why? |
| Macula Lutea | 1 | 2019 | 87 | 0.71 | Why? |
| Lenses, Intraocular | 1 | 2017 | 15 | 0.70 | Why? |
| Fluorocarbons | 1 | 2019 | 102 | 0.70 | Why? |
| Tooth Preparation, Prosthodontic | 1 | 2017 | 1 | 0.70 | Why? |
| Denture, Partial, Fixed | 1 | 2017 | 2 | 0.70 | Why? |
| Dentin Sensitivity | 1 | 2017 | 2 | 0.69 | Why? |
| Crowns | 1 | 2017 | 9 | 0.69 | Why? |
| Nerve Fibers | 1 | 2018 | 73 | 0.68 | Why? |
| Eye Neoplasms | 1 | 2018 | 71 | 0.68 | Why? |
| Riboflavin | 1 | 2017 | 84 | 0.67 | Why? |
| Calcium Phosphates | 1 | 2017 | 35 | 0.67 | Why? |
| Immunoglobulin E | 2 | 2017 | 557 | 0.66 | Why? |
| Retinal Vasculitis | 1 | 2016 | 33 | 0.66 | Why? |
| Optics and Photonics | 1 | 2016 | 57 | 0.65 | Why? |
| Microscopy, Confocal | 5 | 2019 | 343 | 0.65 | Why? |
| Eye Injuries | 1 | 2019 | 128 | 0.65 | Why? |
| Wounds, Nonpenetrating | 1 | 2019 | 157 | 0.63 | Why? |
| Collagen | 1 | 2017 | 222 | 0.61 | Why? |
| Conjunctivitis | 1 | 2020 | 318 | 0.61 | Why? |
| Corneal Opacity | 1 | 2014 | 7 | 0.59 | Why? |
| Corneal Transplantation | 2 | 2018 | 207 | 0.59 | Why? |
| Diabetic Retinopathy | 2 | 2017 | 347 | 0.58 | Why? |
| Macular Edema | 1 | 2017 | 139 | 0.57 | Why? |
| Homeodomain Proteins | 1 | 2015 | 93 | 0.57 | Why? |
| Eye Infections, Viral | 2 | 2021 | 517 | 0.56 | Why? |
| Fundus Oculi | 3 | 2021 | 237 | 0.56 | Why? |
| Photorefractive Keratectomy | 3 | 2018 | 12 | 0.55 | Why? |
| Hand Sanitizers | 1 | 2020 | 397 | 0.54 | Why? |
| Multimodal Imaging | 1 | 2018 | 534 | 0.51 | Why? |
| Retinal Pigment Epithelium | 3 | 2017 | 62 | 0.49 | Why? |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 526 | 0.48 | Why? |
| Laser Therapy | 1 | 2014 | 158 | 0.46 | Why? |
| Follow-Up Studies | 15 | 2019 | 17020 | 0.45 | Why? |
| Elasticity | 3 | 2019 | 70 | 0.44 | Why? |
| Autophagy | 2 | 2018 | 960 | 0.43 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 4 | 2021 | 9706 | 0.42 | Why? |
| Migraine Disorders | 1 | 2018 | 530 | 0.42 | Why? |
| India | 10 | 2021 | 11875 | 0.40 | Why? |
| Mutation, Missense | 1 | 2015 | 863 | 0.38 | Why? |
| Mesenchymal Stem Cell Transplantation | 1 | 2020 | 1322 | 0.38 | Why? |
| Sclera | 2 | 2019 | 31 | 0.37 | Why? |
| Recovery of Function | 1 | 2019 | 2461 | 0.36 | Why? |
| Aqueous Humor | 2 | 2018 | 82 | 0.33 | Why? |
| Corneal Diseases | 3 | 2018 | 172 | 0.33 | Why? |
| Disease Transmission, Infectious | 5 | 2020 | 9044 | 0.33 | Why? |
| Dry Eye Syndromes | 2 | 2019 | 113 | 0.33 | Why? |
| Contact Lenses | 2 | 2019 | 108 | 0.32 | Why? |
| Humans | 72 | 2021 | 930598 | 0.32 | Why? |
| Adult | 37 | 2020 | 244371 | 0.32 | Why? |
| Pharmaceutical Preparations | 1 | 2021 | 1897 | 0.32 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.31 | Why? |
| Glucocorticoids | 2 | 2019 | 4431 | 0.31 | Why? |
| Inflammation Mediators | 1 | 2017 | 2654 | 0.31 | Why? |
| Intravitreal Injections | 2 | 2019 | 347 | 0.30 | Why? |
| Bevacizumab | 2 | 2017 | 149 | 0.30 | Why? |
| Dexamethasone | 1 | 2017 | 2055 | 0.30 | Why? |
| Betacoronavirus | 13 | 2020 | 204454 | 0.29 | Why? |
| Young Adult | 19 | 2020 | 93724 | 0.28 | Why? |
| Prospective Studies | 12 | 2019 | 43301 | 0.26 | Why? |
| Eye | 2 | 2018 | 374 | 0.26 | Why? |
| Male | 39 | 2021 | 367725 | 0.26 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.26 | Why? |
| Biomarkers | 5 | 2019 | 23361 | 0.25 | Why? |
| Biomechanical Phenomena | 3 | 2019 | 291 | 0.25 | Why? |
| Equipment Design | 4 | 2017 | 3095 | 0.25 | Why? |
| Quarantine | 2 | 2020 | 18418 | 0.25 | Why? |
| Female | 36 | 2020 | 380317 | 0.24 | Why? |
| Reproducibility of Results | 6 | 2017 | 11304 | 0.23 | Why? |
| Cytokines | 4 | 2019 | 15010 | 0.23 | Why? |
| Lubricant Eye Drops | 1 | 2020 | 17 | 0.23 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.22 | Why? |
| HLA-B27 Antigen | 1 | 2021 | 48 | 0.22 | Why? |
| Fluorescein | 1 | 2020 | 66 | 0.22 | Why? |
| Pneumonia, Viral | 13 | 2020 | 243684 | 0.22 | Why? |
| Coronavirus Infections | 13 | 2020 | 253789 | 0.22 | Why? |
| Immunity, Active | 1 | 2020 | 31 | 0.21 | Why? |
| Microbubbles | 1 | 2020 | 40 | 0.21 | Why? |
| Adolescent | 12 | 2020 | 86841 | 0.21 | Why? |
| Filtering Surgery | 1 | 2019 | 6 | 0.21 | Why? |
| Time Factors | 7 | 2019 | 31397 | 0.21 | Why? |
| Corneal Keratocytes | 1 | 2019 | 1 | 0.20 | Why? |
| Siloxanes | 1 | 2019 | 8 | 0.20 | Why? |
| Dental Cements | 1 | 2019 | 4 | 0.20 | Why? |
| Lens Capsule, Crystalline | 1 | 2019 | 6 | 0.20 | Why? |
| Dental Veneers | 1 | 2018 | 1 | 0.20 | Why? |
| Presbyopia | 1 | 2018 | 3 | 0.20 | Why? |
| Vertical Dimension | 1 | 2018 | 4 | 0.20 | Why? |
| Tooth, Nonvital | 1 | 2018 | 2 | 0.20 | Why? |
| Dental Occlusion | 1 | 2018 | 2 | 0.20 | Why? |
| Pandemics | 17 | 2021 | 389249 | 0.20 | Why? |
| Tooth Abnormalities | 1 | 2018 | 7 | 0.20 | Why? |
| Resins, Synthetic | 1 | 2018 | 17 | 0.20 | Why? |
| Esthetics, Dental | 1 | 2018 | 24 | 0.20 | Why? |
| Composite Resins | 1 | 2018 | 16 | 0.20 | Why? |
| Prosthodontics | 1 | 2018 | 21 | 0.20 | Why? |
| Adhesives | 1 | 2019 | 31 | 0.19 | Why? |
| Malocclusion | 1 | 2018 | 16 | 0.19 | Why? |
| Polyvinyls | 1 | 2019 | 23 | 0.19 | Why? |
| Tensile Strength | 1 | 2019 | 42 | 0.19 | Why? |
| Biometry | 1 | 2019 | 69 | 0.19 | Why? |
| Optical Imaging | 1 | 2020 | 197 | 0.19 | Why? |
| Angiogenesis Inhibitors | 3 | 2017 | 395 | 0.19 | Why? |
| Endothelium, Corneal | 1 | 2019 | 41 | 0.19 | Why? |
| Personal Protective Equipment | 2 | 2021 | 15978 | 0.19 | Why? |
| Phacoemulsification | 1 | 2020 | 102 | 0.18 | Why? |
| Extracellular Matrix Proteins | 1 | 2019 | 95 | 0.18 | Why? |
| Dopamine | 1 | 2019 | 123 | 0.18 | Why? |
| Monophenol Monooxygenase | 1 | 2017 | 11 | 0.18 | Why? |
| Bowman Membrane | 1 | 2017 | 1 | 0.18 | Why? |
| Lasers | 1 | 2018 | 132 | 0.18 | Why? |
| Crystallization | 1 | 2019 | 331 | 0.17 | Why? |
| Air | 1 | 2018 | 145 | 0.17 | Why? |
| Personality | 1 | 2021 | 277 | 0.17 | Why? |
| Cementation | 1 | 2017 | 4 | 0.17 | Why? |
| Anterior Eye Segment | 1 | 2017 | 23 | 0.17 | Why? |
| Iris | 1 | 2017 | 27 | 0.17 | Why? |
| Contrast Sensitivity | 1 | 2017 | 8 | 0.17 | Why? |
| Bicuspid | 1 | 2017 | 9 | 0.17 | Why? |
| Melanocytes | 1 | 2017 | 44 | 0.17 | Why? |
| Drug Implants | 1 | 2017 | 43 | 0.17 | Why? |
| Health Care Sector | 1 | 2020 | 191 | 0.17 | Why? |
| Healthy Volunteers | 3 | 2019 | 1444 | 0.17 | Why? |
| Lens Implantation, Intraocular | 1 | 2017 | 62 | 0.17 | Why? |
| Pilot Projects | 2 | 2021 | 5182 | 0.17 | Why? |
| Manometry | 1 | 2017 | 91 | 0.17 | Why? |
| Retinal Pigments | 1 | 2016 | 2 | 0.16 | Why? |
| Visual Analog Scale | 1 | 2017 | 151 | 0.16 | Why? |
| Vitreoretinopathy, Proliferative | 1 | 2016 | 16 | 0.16 | Why? |
| Fluorescent Dyes | 1 | 2020 | 536 | 0.16 | Why? |
| Awards and Prizes | 1 | 2017 | 101 | 0.16 | Why? |
| ROC Curve | 3 | 2017 | 6024 | 0.16 | Why? |
| Materials Testing | 1 | 2019 | 380 | 0.15 | Why? |
| Fluoroquinolones | 1 | 2017 | 235 | 0.15 | Why? |
| Treatment Outcome | 7 | 2020 | 51732 | 0.15 | Why? |
| Pemphigoid, Bullous | 1 | 2017 | 89 | 0.15 | Why? |
| Diagnostic Imaging | 2 | 2021 | 1044 | 0.15 | Why? |
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 245 | 0.15 | Why? |
| Glaucoma | 1 | 2019 | 225 | 0.14 | Why? |
| Postoperative Period | 1 | 2017 | 651 | 0.14 | Why? |
| Tissue Scaffolds | 1 | 2016 | 174 | 0.14 | Why? |
| Photosensitizing Agents | 1 | 2017 | 279 | 0.14 | Why? |
| Photography | 1 | 2017 | 255 | 0.14 | Why? |
| Cell Adhesion Molecules | 1 | 2017 | 472 | 0.14 | Why? |
| Reoperation | 1 | 2017 | 544 | 0.14 | Why? |
| Sarcoidosis | 1 | 2018 | 271 | 0.13 | Why? |
| Gene Expression Regulation | 2 | 2018 | 4020 | 0.13 | Why? |
| Pedigree | 1 | 2015 | 502 | 0.13 | Why? |
| Morbidity | 1 | 2020 | 1426 | 0.13 | Why? |
| Chronic Disease | 2 | 2019 | 5139 | 0.13 | Why? |
| Induced Pluripotent Stem Cells | 1 | 2018 | 584 | 0.13 | Why? |
| Cross-Over Studies | 1 | 2017 | 867 | 0.13 | Why? |
| Wound Healing | 1 | 2017 | 424 | 0.13 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.13 | Why? |
| Interprofessional Relations | 1 | 2020 | 1013 | 0.12 | Why? |
| Contrast Media | 1 | 2019 | 1011 | 0.12 | Why? |
| Child | 5 | 2021 | 70012 | 0.12 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2016 | 604 | 0.11 | Why? |
| Immunomodulation | 1 | 2020 | 1472 | 0.11 | Why? |
| Haplotypes | 1 | 2015 | 853 | 0.11 | Why? |
| Reactive Oxygen Species | 1 | 2017 | 1136 | 0.11 | Why? |
| Chemokines | 1 | 2017 | 1095 | 0.11 | Why? |
| Reconstructive Surgical Procedures | 1 | 2021 | 860 | 0.11 | Why? |
| Stem Cells | 1 | 2016 | 595 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Goats | 2 | 2020 | 217 | 0.10 | Why? |
| Cells, Cultured | 2 | 2019 | 5835 | 0.10 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2019 | 11367 | 0.10 | Why? |
| Animals | 8 | 2020 | 78931 | 0.10 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.10 | Why? |
| Area Under Curve | 1 | 2017 | 2564 | 0.10 | Why? |
| Molecular Sequence Data | 1 | 2015 | 3198 | 0.10 | Why? |
| Middle Aged | 15 | 2019 | 270681 | 0.10 | Why? |
| Nanostructures | 1 | 2016 | 700 | 0.10 | Why? |
| Retrospective Studies | 10 | 2019 | 105322 | 0.09 | Why? |
| Iridocyclitis | 1 | 2007 | 2 | 0.09 | Why? |
| Postoperative Complications | 2 | 2017 | 5861 | 0.09 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.09 | Why? |
| RNA | 1 | 2016 | 1278 | 0.09 | Why? |
| Environmental Monitoring | 1 | 2020 | 3143 | 0.09 | Why? |
| Ultraviolet Rays | 1 | 2017 | 1272 | 0.09 | Why? |
| Comorbidity | 3 | 2021 | 34796 | 0.09 | Why? |
| Scleritis | 1 | 2007 | 25 | 0.09 | Why? |
| Retinitis | 1 | 2007 | 42 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2019 | 3788 | 0.08 | Why? |
| Guidelines as Topic | 1 | 2020 | 2844 | 0.08 | Why? |
| Base Sequence | 1 | 2015 | 3581 | 0.08 | Why? |
| Antihypertensive Agents | 1 | 2019 | 1962 | 0.08 | Why? |
| Alphavirus Infections | 1 | 2007 | 68 | 0.08 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.07 | Why? |
| Remote Consultation | 1 | 2020 | 2396 | 0.07 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.07 | Why? |
| Epithelial Cells | 1 | 2017 | 3508 | 0.07 | Why? |
| Autoimmune Diseases | 1 | 2018 | 1996 | 0.07 | Why? |
| Immunity, Cellular | 1 | 2018 | 3614 | 0.07 | Why? |
| Referral and Consultation | 1 | 2021 | 4816 | 0.07 | Why? |
| Chikungunya virus | 1 | 2007 | 339 | 0.07 | Why? |
| RNA, Messenger | 1 | 2018 | 5131 | 0.06 | Why? |
| Chloroquine | 1 | 2018 | 3152 | 0.06 | Why? |
| Amino Acid Sequence | 1 | 2015 | 6049 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.06 | Why? |
| Cross-Sectional Studies | 4 | 2019 | 53120 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2018 | 4545 | 0.06 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.06 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.06 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.05 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.05 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2018 | 5837 | 0.05 | Why? |
| Keratotomy, Radial | 1 | 2019 | 2 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Computational Biology | 1 | 2015 | 4514 | 0.05 | Why? |
| Sensitivity and Specificity | 2 | 2018 | 22971 | 0.05 | Why? |
| Finite Element Analysis | 1 | 2018 | 27 | 0.05 | Why? |
| Cell Proliferation | 2 | 2017 | 1973 | 0.05 | Why? |
| Keratoplasty, Penetrating | 1 | 2019 | 75 | 0.05 | Why? |
| Flow Cytometry | 2 | 2018 | 2393 | 0.05 | Why? |
| Tooth | 1 | 2018 | 42 | 0.05 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.05 | Why? |
| Ophthalmoscopy | 1 | 2018 | 65 | 0.05 | Why? |
| Prostheses and Implants | 1 | 2019 | 116 | 0.05 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.04 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.04 | Why? |
| Miniaturization | 1 | 2017 | 29 | 0.04 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Angiogenic Proteins | 1 | 2017 | 14 | 0.04 | Why? |
| Prosthesis Fitting | 1 | 2017 | 12 | 0.04 | Why? |
| Matrix Metalloproteinase 9 | 1 | 2018 | 211 | 0.04 | Why? |
| CD4-CD8 Ratio | 1 | 2018 | 235 | 0.04 | Why? |
| Models, Animal | 1 | 2020 | 788 | 0.04 | Why? |
| Dose-Response Relationship, Drug | 2 | 2017 | 3776 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2018 | 501 | 0.04 | Why? |
| Slit Lamp Microscopy | 1 | 2018 | 164 | 0.04 | Why? |
| Ophthalmic Solutions | 1 | 2017 | 136 | 0.04 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.04 | Why? |
| Preoperative Period | 1 | 2017 | 271 | 0.04 | Why? |
| Administration, Topical | 1 | 2017 | 272 | 0.04 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.04 | Why? |
| Protective Agents | 1 | 2018 | 250 | 0.04 | Why? |
| Anxiety | 1 | 2021 | 17311 | 0.04 | Why? |
| Epithelium | 1 | 2017 | 330 | 0.04 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2017 | 242 | 0.04 | Why? |
| Regenerative Medicine | 1 | 2016 | 161 | 0.04 | Why? |
| Prosthesis Design | 1 | 2017 | 594 | 0.03 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.03 | Why? |
| Blotting, Western | 1 | 2016 | 863 | 0.03 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2017 | 669 | 0.03 | Why? |
| Immunophenotyping | 1 | 2018 | 1290 | 0.03 | Why? |
| Cadaver | 1 | 2016 | 626 | 0.03 | Why? |
| NF-kappa B | 1 | 2018 | 1301 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.03 | Why? |
| Cell Differentiation | 1 | 2016 | 1338 | 0.03 | Why? |
| Nanotechnology | 1 | 2016 | 821 | 0.03 | Why? |
| Rats | 1 | 2017 | 2764 | 0.02 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.02 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.02 | Why? |
| Diclofenac | 1 | 2007 | 27 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Acyclovir | 1 | 2007 | 154 | 0.02 | Why? |
| Prednisolone | 1 | 2007 | 443 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 7868 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Signal Transduction | 1 | 2016 | 7207 | 0.01 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2018 | 6166 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 13720 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.01 | Why? |
| Drug Therapy, Combination | 1 | 2007 | 7268 | 0.01 | Why? |
| Immunoglobulin M | 1 | 2007 | 9091 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2017 | 88759 | 0.01 | Why? |
| Antiviral Agents | 1 | 2007 | 41703 | 0.00 | Why? |